| Identification | Back Directory | [Name]
Furanodiene | [CAS]
19912-61-9 | [Synonyms]
Furanodiene
Furanodiene ISO 9001：2015 REACH
3,6,10-Trimethyl-4,7,8,11-tetrahydro-cyclodeca[B]furan
(5E)-3,6,10-Trimethyl-4,7,8,11-tetrahydrocyclodeca[B]furan
(5E,9Z)-4,7,8,11-Tetrahydro-3,6,10-trimethylcyclodeca[b]furan
Cyclodeca[B]furan, 4,7,8,11-tetrahydro-3,6,10-trimethyl-, (5E)-
Cyclodeca[b]furan, 4,7,8,11-tetrahydro-3,6,10-trimethyl-, (5E,9Z)-
Inchi=1/C15H20o/C1-11-5-4-6-12(2)9-15-14(8-7-11)13(3)10-16-15/H6-7,10H,4-5,8-9H2,1-3H3/B11-7+,12-6 | [Molecular Formula]
C15H20O | [MDL Number]
MFCD30479113 | [MOL File]
19912-61-9.mol | [Molecular Weight]
216.32 |
| Chemical Properties | Back Directory | [Melting point ]
74-75 °C | [Boiling point ]
309.6±11.0 °C(Predicted) | [density ]
0.945±0.06 g/cm3(Predicted) | [form ]
Solid | [color ]
Off-white to light yellow | [LogP]
5.369 (est) | [CAS DataBase Reference]
19912-61-9 |
| Hazard Information | Back Directory | [Hazard]
A poison by ingestion. | [Anticancer Research]
Tested on uterine cervical (UI4) and sarcoma 180 (S180) tumors in mice, the furanodienehas a significant tumor inhibition rate dose-dependent. The furanodienewas administered intraperitoneally as liposome. The effect of furanodiene on theinhibition of cell proliferation by activation of apoptosis was not hypothesized(Song et al. 2014, Zielińska and Matkowski 2014, Polo et al. 2013). |
|
|